Alnylam Pharmaceuticals

Director, Clinical Research

Alnylam Pharmaceuticals$255K — $345K *
Pharmaceuticals & Biotech
Less than 5 years of experience
Job Overview by Ladders

Qualifications

  • MD or MD-PhD with strong research background and peer-reviewed publications
  • Board Certified or specialist training in cardiology
  • Expertise in heart failure and/or amyloidosis preferred
  • 3+ years of industry experience or equivalent clinical academic experience
  • Familiarity with clinical research concepts and trial design
  • Outstanding leadership and collaboration skills in a matrix environment
  • Experience working with biotech/pharma partners

Responsibilities

  • Lead strategic initiatives for the clinical program
  • Develop innovative approaches for drug development
  • Oversee trial conduct and ensure participant safety
  • Consult with research teams on clinically significant decisions
  • Collaborate with cross-functional teams for integrated development plans
  • Manage timelines and deliverables in Clinical Research and Operations
  • Review and authorize critical clinical documents and presentations

Benefits

  • Comprehensive medical, dental, and vision insurance
  • Life and disability insurance
  • Lifestyle reimbursement program
  • 401(k) with generous company match
  • Paid time off, wellness days, and holidays
  • Generous family resources and leave policy
Full Job Description
Overview

The successful candidate's primary role will be as one of the clinical leads in a clinical development program in ATTR amyloidosis. He/she will report directly into the program medical lead who provides the clinical research oversight of the program. He/she is expected to play a leading and influencing role in the overall clinical development strategies for the molecules and drive progress and operational excellence for associated clinical trials. In addition, this role will include interaction with Alnylam's research group, helping to advise the team on the clinical development feasibility of novel targets and the design of proof-of-concept studies. This work will also involve extensive consultation and collaboration with external experts. It is anticipated that additional opportunities will arise to lead bench-to-bedside early phase clinical development programs. The Director, Clinical Research, will work in a matrix organization across Regulatory, Biostatistics, Clinical Operations, Preclinical, Commercial & Quality Assurance teams to ensure fully harmonized and integrated development strategies. He/she will be a key Alnylam Development spokesperson at external meetings, including regulatory interactions and scientific meetings.

*This a hybrid position with 2 days a week onsite presence in our Cambridge, MA or Philadelphia, PA office required.

Key Responsibilities
• Be the strategic leader providing a strong, clear voice for the clinical program.
• Develop creative but realistic approaches to drug development and lead clinical efforts to secure global regulatory approvals.
• Oversight of trial conduct and safety
• Provide strategic consultation and guidance to Research on all decisions that have significant clinical components and implications.
• Collaborate closely with Preclinical, Regulatory Affairs and Medical Affairs to ensure tight strategic integration of product development plans.
• Be accountable via Clinical Research and Operations for all relevant timelines and deliverables.
• Supervise closely all major written deliverables (regulatory submissions, original articles, abstracts), and presentation materials.
• Be responsible for final review and sign off with respect to all controlled documents including protocols, investigator brochures, and informed consent forms.
• Influence internal and external audiences in a high impact, highly visible fashion

Qualifications

A highly driven, dynamic, engaged and accomplished physician-scientist with experience and insight will thrive in this role. Specific qualifications include:

MD with strong research background or MD PhD with best of class clinical and/or research training as shown through research support and peer-reviewed publications.
Board Certification (or equivalent) or specialist training in cardiology

Expertise in heart failure and/or amyloidosis is desirable

3+ years industry experience or equivalent clinical academic experience
Sound scientific and clinical judgment

Familiarity with concepts of clinical research and clinical trial design, including biostatistics, and regulatory agency organization, guidelines, and practices
Ability to effectively present ideas and document complex medical/clinical concepts in both written and oral communication
History of solving problems while exhibiting superior judgment and a balanced, realistic understanding of issues
Outstanding leadership and collaboration skills working within a matrix environment
Experience and knowledge of working with biotech/pharma partner(s)
Thrives in highly entrepreneurial biotech environment and embraces Alnylam's culture of science, passion and urgency.

#LI-JB1 #LI-Hybrid

U.S. Pay Range

$255,000.00 - $345,000.00

The pay range reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).

Alnylam's robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.

Learn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website: https://www.alnylam.com/careers

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals is a biotechnology company that focuses on RNA interference (RNAi) therapeutics. The company's products are designed to silence specific genes that cause diseases. Alnylam's pipeline includes products for the treatment of genetic, cardio-metabolic, and hepatic infectious diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Learn more about Alnylam Pharmaceuticals
Size
1,665 employees
Market Cap
$28.7 billion
Industry
Net Income
-$858.2 million
Founded
2002
5 Year Trend
+78.1%
Revenue
$492.8 million
NASDAQ

Similar Jobs

More Jobs at Alnylam Pharmaceuticals

More Pharmaceuticals & Biotech Jobs

Find similar Director, Clinical Research jobs: